We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Bring photo ID to vote Check what photo ID you'll need to vote in person in the General Election on 4 July.
There is a risk of harmful drug interactions with the ritonavir component of the COVID-19 treatment Paxlovid▼ due to its inhibition of the enzyme CYP3A, which metabolises many commonly used drugs. Prescribers should obtain a detailed patient history of current...
The review aims to provide a comprehensive picture of the use and supply of illicit drugs and to identify what more could be done to reduce harm to individuals and society.
Government response to the 12th report from the home affairs committee session.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Find drug safety updates issued by MHRA
The most commonly encountered drugs currently controlled under the misuse of drugs legislation.
A qualitative study
Science and Technology Secretary announces that the Diamond Light Source science facility in Oxfordshire will be upgraded through a £500 million investment.
A report for the Secretary of State for Health by Professor Sir Mike Richards CBE
The first part of Dame Carol Black's independent review of drugs.
SDSSC 21st century Drugs and Statistical Science in the UK report
Monthly PDF editions of the Drug Safety Update newsletter from MHRA and its independent advisor, the Commission on Human Medicines
This is your opportunity to share your views on the white paper.
This series brings together all documents relating to drugs licensing.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).